Monday - July 27, 2026
Goodwin Represents Parabilis Medicines in Strategic Collaboration With Regeneron Pharmaceuticals for Up to $2.3 Billion
June 12, 2026
BOSTON, Massachusetts, June 12 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:

* * *

Goodwin Represents Parabilis Medicines in Strategic Collaboration With Regeneron Pharmaceuticals for Up to $2.3 Billion

*

The Life Sciences team represented Parabilis Medicines in a strategic global collaboration with Regeneron Pharmaceuticals to discover and develop therapeutic candidates based on Parabilis' Helicon(tm) . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products